mayoclinicproceedings.orgProton Pump Inhibitors: Review of Emerging Concerns
First introduced in 1989, proton pump inhibitors (PPIs) are among the most widely utilized medications worldwide, both in the ambulatory and inpatient clinical settings. The PPIs are currently approved by the US Food and Drug Administration for the management of a variety of gastrointestinal disorders including symptomatic peptic ulcer disease, gastroesophageal reflux disease, and nonulcer dyspepsia as well as for prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy.
Read More
First mixed this
  • Biology
  • Health Care
  • FDA
  • Diseases
    Load More